BAY 43-9006 (sorafenib)

sorafenib · Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAY 43-9006 (sorafenib), covering 2010-04-08 to 2010-04-08. Get the full timeline:

Most recent: Clinical Trial Update: BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) [Phase 2]